This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients. Blake has a unique case because he was a cardiac, cath lab, critical care, and surgery nurse who got into medical sales.
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. If you apply the right AI engines, you will get increasingly better insights. But that’s just the beginning.
Dr Boshoff is the ideal leader to propel Pfizer’s R&D engine forward…with a more focused strategy, driving the delivery of additional impactful breakthrough medicines with blockbuster potential,” stated Dr Albert Bourla , Chairman and Chief Executive Officer. Academy of MedicalSciences. “I
If a misinterpretation exists between engineers and testers on the solution developed, then such requirements will have higher risks on the entire lifecycle. For example, insights from healthcare providers (HCPs) might be filtered through a medicalscience liaison’s interpretations, leading to gaps in the captured requirements.
About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Most recently, Imran has served as MedicalScience Liaison (MSL) Head, Oncology U.S. Medical Affairs. CAR T Cells: Engineering Immune Cells to Treat Cancer [Internet]. Cancer.gov.
Schema markup is one of the levers that search engine optimization (SEO) specialists can leverage. Yet, it is surprisingly underutilized, making it an opportune way to increase your healthcare organization’s visibility on search engine results pages (SERPs). But where do you start?
Thanks to kind support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below), we met with Ronan Castro, the CEO of Human Xtensions at the company’s offices in Netanya, Israel. More info can be found at the Biomed Israel website.
with Fred Colen as he shares his transformation from an engineer to a MedTech executive. It’s one of those interviews that can stick with you and inspire you as you continue to go on and lead the wonderful career you are trying to lead. Do I want to be a medical doctor or an engineer? Take us back to college.
This leads to substantial damage to healthy tissues and too often results in poor outcomes. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. which are currently recruiting patients.
1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. About the author Dr Mehrdad Mobasher, MPH, is the Chief Medical Officer for Hematology at BeiGene.
These engineered T cells have shown remarkable efficacy in identifying and destroying multiple myeloma cells. Hait: When leading R&D at Johnson & Johnson , the World Without Disease Accelerator revolutionized healthcare by focusing on disease prevention rather than merely treating diseases. Dr. William N.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content